KHAPZORY

Serial Number 88165625
Registration 5898750
700

Registration Progress

Application Filed
Oct 23, 2018
Under Examination
Mar 12, 2019
Approved for Publication
Jan 15, 2019
Published for Opposition
Jan 15, 2019
Registered
Oct 29, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-10-29)
Due: Oct 29, 2025 112 days

Basic Information

Serial Number
88165625
Registration Number
5898750
Deadline
October 29, 2025
Description
5 Year - Section 8 and 15 Renewal
Filing Date
October 23, 2018
Registration Date
October 29, 2019
Published for Opposition
January 15, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 29, 2019
Registration
Registered
Classes
005

Rights Holder

ACROTECH BIOPHARMA INC.

03
Address
279 PRINCETON HIGHTSTOWN ROAD
EAST WINDSOR, NJ 08520

Ownership History

Spectrum Pharmaceuticals, Inc.

Original Applicant
03
Irvine, CA

Spectrum Pharmaceuticals, Inc.

Owner at Publication
03
Irvine, CA

ACROTECH BIOPHARMA LLC

New Owner After Publication #1
16
EAST WINDSOR, NJ

ACROTECH BIOPHARMA LLC

Original Registrant
16
EAST WINDSOR, NJ

ACROTECH BIOPHARMA INC.

New Owner After Registration #1
03
EAST WINDSOR, NJ

Legal Representation

Attorney
Lynn E. Rzonca

USPTO Deadlines

Next Deadline
112 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-10-29)
Due Date
October 29, 2025
Grace Period Ends
April 29, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description
Oct 29, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 5, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 5, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 5, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 5, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 5, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 14, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 29, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 29, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 29, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 29, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 29, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 29, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 26, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 25, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 23, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Sep 20, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 27, 2019 IUAF S USE AMENDMENT FILED
Aug 27, 2019 EISU I TEAS STATEMENT OF USE RECEIVED
Jun 5, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 12, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 15, 2019 PUBO A PUBLISHED FOR OPPOSITION
Jan 15, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2018 DOCK D ASSIGNED TO EXAMINER
Nov 4, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications that is precipitate free when mixed other folate antagonists
First Use Anywhere: Dec 10, 2018
First Use in Commerce: Dec 10, 2018

Classification

International Classes
005